Distilled spirits maker MGP Ingredients beats Q3 sales expectations, hikes FY profit view

Reuters
10/29
Distilled spirits maker <a href="https://laohu8.com/S/MGPI">MGP Ingredients</a> beats Q3 sales expectations, hikes FY profit view

Overview

  • MGP Ingredients Q3 sales fell 19% but beat analyst expectations

  • Adjusted EPS for Q3 decreased 34% to $0.85

  • Company raises full-year adjusted EBITDA and EPS outlook

Outlook

  • MGP Ingredients raises full-year adjusted EBITDA guidance to $110 mln-$115 mln

  • Company tightens full-year sales guidance to $525 mln-$535 mln

  • MGP Ingredients increases full-year adjusted EPS outlook to $2.60-$2.75

Result Drivers

  • BROWN GOODS DECLINE - Sales decrease primarily due to expected declines in brown goods

  • PREMIUM PLUS GROWTH - Premium plus brands delivered solid growth, with Penelope Bourbon maintaining strong growth

  • INGREDIENT SOLUTIONS SALES INCREASE - Sales rose 9% due to higher wheat protein sales, despite operational challenges

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$130.90 mln

$128 mln (6 Analysts)

Q3 EPS

$0.71

Q3 Net Income

$15.40 mln

Q3 Adjusted EBITDA

$32.29 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the distillers & wineries peer group is "buy"

  • Wall Street's median 12-month price target for MGP Ingredients Inc is $38.00, about 37.7% above its October 28 closing price of $23.67

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nBw3CFH6Ta

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10